Chuan Xing

909 total citations
28 papers, 600 citations indexed

About

Chuan Xing is a scholar working on Reproductive Medicine, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chuan Xing has authored 28 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Reproductive Medicine, 9 papers in Molecular Biology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chuan Xing's work include Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (8 papers) and Hormonal and reproductive studies (6 papers). Chuan Xing is often cited by papers focused on Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (8 papers) and Hormonal and reproductive studies (6 papers). Chuan Xing collaborates with scholars based in China and United States. Chuan Xing's co-authors include Bing He, Han Zhao, Jiaqi Zhang, Chun‐Zhu Li, Wenjing Shi, Jiaqi Zhang, Eddy S. Yang, Ling Zeng, Hongxing Shen and Anatoly Nikolaev and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Chuan Xing

25 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuan Xing China	15	267	178	163	114	102	28	600
Maria Magdalena Montt Guevara Italy	14	53 0.2×	150 0.8×	64 0.4×	101 0.9×	66 0.6×	32	516
Miloš Lazić United States	10	115 0.4×	390 2.2×	80 0.5×	110 1.0×	141 1.4×	14	803
Qiuwan Zhang China	13	139 0.5×	223 1.3×	157 1.0×	10 0.1×	27 0.3×	17	597
Erlisa Bardhi Italy	10	235 0.9×	162 0.9×	132 0.8×	15 0.1×	26 0.3×	16	493
Mélissa Buscato France	13	37 0.1×	131 0.7×	55 0.3×	127 1.1×	53 0.5×	26	453
Malgorzata McMenamin United States	11	55 0.2×	228 1.3×	122 0.7×	20 0.2×	36 0.4×	18	524
Hillary Dinh United States	6	40 0.1×	82 0.5×	38 0.2×	261 2.3×	32 0.3×	11	462
Federica Todaro Italy	12	58 0.2×	131 0.7×	56 0.3×	14 0.1×	57 0.6×	20	324
Ruibao Chen China	14	83 0.3×	312 1.8×	68 0.4×	53 0.5×	15 0.1×	32	609
Canqiao Luo China	9	90 0.3×	83 0.5×	35 0.2×	48 0.4×	20 0.2×	13	374

Countries citing papers authored by Chuan Xing

Since Specialization

Citations

This map shows the geographic impact of Chuan Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Xing more than expected).

Fields of papers citing papers by Chuan Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Xing. The network helps show where Chuan Xing may publish in the future.

Co-authorship network of co-authors of Chuan Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Xing. A scholar is included among the top collaborators of Chuan Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Xing. Chuan Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xing, Chuan & Xiang Yu. (2025). Oxytocin and autism: Insights from clinical trials and animal models. Current Opinion in Neurobiology. 92. 103015–103015.

Shen, Hongxing, Haitao Ding, Chuan Xing, et al.. (2024). HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cells. Nature Communications. 15(1). 9394–9394. 21 indexed citations

Xing, Chuan, Yanping Liu, Qiuhua Yang, et al.. (2023). Aerobic exercise and metformin on intermuscular adipose tissue (IMAT): insights from multimodal MRI and histological changes in prediabetic rats. Diabetology & Metabolic Syndrome. 15(1). 221–221. 2 indexed citations

Wang, Dongxu, et al.. (2023). Androgens exacerbate hepatic triglyceride accumulation in rats with polycystic ovary syndrome by downregulating MTTP expression. Endocrine. 84(2). 735–744. 3 indexed citations

Zhao, Han, et al.. (2023). Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α. The Journal of Steroid Biochemistry and Molecular Biology. 229. 106265–106265. 8 indexed citations

Xing, Chuan, Jiaqi Zhang, Han Zhao, & Bing He. (2022). Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment. SHILAP Revista de lepidopterología. 62 indexed citations

Anderson, Joshua C., Zongliang Yue, Thanh Nguyen, et al.. (2022). An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases. JCI Insight. 7(16). 12 indexed citations

Yang, Yiming, Veronika Kozlovskaya, Zhuo Zhang, et al.. (2022). Poly(N-vinylpyrrolidone)-block-Poly(dimethylsiloxane)-block-Poly(N-vinylpyrrolidone) Triblock Copolymer Polymersomes for Delivery of PARP1 siRNA to Breast Cancers. ACS Applied Bio Materials. 5(4). 1670–1682. 20 indexed citations

Xing, Chuan, et al.. (2022). Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol. BMJ Open. 12(4). e058260–e058260. 3 indexed citations

10.

Xing, Chuan, et al.. (2022). Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial. Frontiers in Endocrinology. 13. 1003238–1003238. 27 indexed citations

11.

Xing, Chuan, Han Zhao, Jiaqi Zhang, & Bing He. (2022). The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis. Frontiers in Physiology. 13. 741285–741285. 9 indexed citations

12.

Xing, Chuan, Han Zhao, Jiaqi Zhang, & Bing He. (2022). Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome. Frontiers in Endocrinology. 13. 945609–945609. 38 indexed citations

13.

Zhang, Zhuo, Lin Luo, Chuan Xing, et al.. (2022). Abstract 2101: RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T cell-dependent anti-tumor immunity. Cancer Research. 82(12_Supplement). 2101–2101. 1 indexed citations

14.

Li, Chun‐Zhu, Chuan Xing, Jiaqi Zhang, et al.. (2021). Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome. Journal of Translational Medicine. 19(1). 148–148. 95 indexed citations

15.

Zhao, Han, Chuan Xing, Jiaqi Zhang, & Bing He. (2021). Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reproductive Health. 18(1). 171–171. 64 indexed citations

16.

Shi, Wenjing, et al.. (2021). Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4275–4281. 11 indexed citations

17.

Xing, Chuan, et al.. (2021). Effects of bariatric surgery on the menstruation- and reproductive-related hormones of women with obesity without polycystic ovary syndrome: a systematic review and meta-analysis. Surgery for Obesity and Related Diseases. 18(1). 148–160. 16 indexed citations

18.

Zhang, Zhuo, Lin Luo, Chuan Xing, et al.. (2021). RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity. Nature Cancer. 2(10). 1018–1038. 20 indexed citations

19.

Zeng, Ling, et al.. (2020). CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 19(6). 1279–1288. 31 indexed citations

20.

Zeng, Ling, Drexell H. Boggs, Chuan Xing, et al.. (2020). Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth. Frontiers in Genetics. 11. 1036–1036. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact